Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 3
2012 1
2013 1
2015 1
2018 1
2019 2
2020 1
2021 3
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis.
Gasparri ML, Albasini S, Truffi M, Favilla K, Tagliaferri B, Piccotti F, Bossi D, Armatura G, Calcinotto A, Chiappa C, Combi F, Curcio A, Della Valle A, Ferrari G, Folli S, Ghilli M, Listorti C, Mancini S, Marinello P, Mele S, Pertusati A, Roncella M, Rossi L, Rovera F, Segattini S, Sgarella A, Tognali D, Corsi F. Gasparri ML, et al. Among authors: tagliaferri b. Ther Adv Med Oncol. 2023 Sep 15;15:17588359231193732. doi: 10.1177/17588359231193732. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37720495 Free PMC article.
Role of androgen receptor expression in early stage ER+/PgR-/HER2- breast cancer.
Tagliaferri B, Quaquarini E, Palumbo R, Balletti E, Presti D, Malovini A, Agozzino M, Teragni CM, Terzoni A, Bernardo A, Villani L, Sottotetti F. Tagliaferri B, et al. Ther Adv Med Oncol. 2020 Sep 17;12:1758835920958355. doi: 10.1177/1758835920958355. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32994808 Free PMC article.
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.
Quaquarini E, Sottotetti F, Agustoni F, Pozzi E, Malovini A, Teragni CM, Palumbo R, Saltalamacchia G, Tagliaferri B, Balletti E, Rinaldi P, Canino C, Pedrazzoli P, Bernardo A. Quaquarini E, et al. Among authors: tagliaferri b. J Pers Med. 2022 Apr 24;12(5):679. doi: 10.3390/jpm12050679. J Pers Med. 2022. PMID: 35629102 Free PMC article.
The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors.
Sottotetti F, Ferraris E, Tagliaferri B, Palumbo R, Quaquarini E, Teragni C, Balletti E, Leli C, Premoli A, Mollica L, Puglisi S, Sardi S, Malovini A, Pedrazzoli P, Bernardo A. Sottotetti F, et al. Among authors: tagliaferri b. Drugs Context. 2022 Sep 5;11:2022-1-3. doi: 10.7573/dic.2022-1-3. eCollection 2022. Drugs Context. 2022. PMID: 36118250 Free PMC article.
Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2- breast cancer treated with CDK4/6 inhibitors and endocrine therapy.
Tagliaferri B, Mollica L, Palumbo R, Leli C, Malovini A, Terzaghi M, Quaquarini E, Teragni C, Maccarone S, Premoli A, Sottotetti F. Tagliaferri B, et al. Drugs Context. 2023 Jun 20;12:2023-1-7. doi: 10.7573/dic.2023-1-7. eCollection 2023. Drugs Context. 2023. PMID: 37378079 Free PMC article.
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
Torrisi R, Palumbo R, De Sanctis R, Vici P, Bianchi GV, Cortesi L, Leonardi V, Gueli R, Fabi A, Valerio MR, Gambaro AR, Tagliaferri B, Pizzuti L, Cazzaniga ME, Santoro A. Torrisi R, et al. Among authors: tagliaferri b. Breast Cancer Res Treat. 2021 Nov;190(1):103-109. doi: 10.1007/s10549-021-06371-9. Epub 2021 Aug 27. Breast Cancer Res Treat. 2021. PMID: 34453206
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.
Di Cosimo S, Tagliaferri B, Generali D, Giudici F, Agustoni F, Bernardo A, Borgonovo K, Farina G, Luchena G, Luciani A, Nolè F, Palmeri L, Pietrantonio F, Poggi G, Zucali PA, Balletti E, Catania G, Bernocchi O, D'Antonio F, Giordano M, Grossi F, Lasagna A, La Verde N, Manzoni M, Montagna B, Olgiati A, Raimondi A, Rampinelli I, Verri E, Zaniboni A, Di Maio M, Beretta G, Danova M. Di Cosimo S, et al. Among authors: tagliaferri b. Cancers (Basel). 2021 Mar 16;13(6):1324. doi: 10.3390/cancers13061324. Cancers (Basel). 2021. PMID: 33809465 Free PMC article.
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study.
Palumbo R, Torrisi R, Sottotetti F, Presti D, Rita Gambaro A, Collovà E, Ferzi A, Agostinetto E, Maria Teragni C, Saltalamacchia G, Tagliaferri B, Balletti E, Bernardo A, Quaquarini E. Palumbo R, et al. Among authors: tagliaferri b. Ther Adv Med Oncol. 2021 Mar 10;13:1758835920987651. doi: 10.1177/1758835920987651. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33796150 Free PMC article.
Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.
Sevieri M, Andreata F, Mainini F, Signati L, Piccotti F, Truffi M, Bonizzi A, Sitia L, Pigliacelli C, Morasso C, Tagliaferri B, Corsi F, Mazzucchelli S. Sevieri M, et al. Among authors: tagliaferri b. J Nanobiotechnology. 2024 Apr 15;22(1):184. doi: 10.1186/s12951-024-02441-4. J Nanobiotechnology. 2024. PMID: 38622644 Free PMC article.
21 results